GlassScriptPhysician profile
John M Magner
NPI 1548374192
$2,712.97
in general payments reported to CMS, 2019-2025
22 companies · $21.58 in 2025
The $21.58 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $964 · 2020: $318 · 2021: $187 · 2022: $402 · 2023: $373 · 2024: $447 · 2025: $21.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $842.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $841.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $594.86 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $531.84 | 2019-2020 | |
| Pfizer INC. | $299.63 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $290.56 | 2019-2024 | |
| Novo Nordisk INC | $162.61 | 2020-2024 | Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $115.34 | 2019-2024 | Pifeltro, Delstrigo, Vaxneuvance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $98.51 | 2019 | |
| Sanofi Pasteur INC. | $88.89 | 2019 | |
| Exact Sciences Corporation | $72.33 | 2023-2024 | Cologuard Collection Kit |
| Lilly USA, LLC | $69.79 | 2019-2023 | Jardiance |
| Nestle Healthcare Nutrition INC. | $52.08 | 2022 | |
| Viiv Healthcare Company | $46.33 | 2023 | Rukobia, Cabenuva |
| Theratechnologies INC. | $42.99 | 2023 | Egrifta, Trogarzo |
| Sunovion Pharmaceuticals INC. | $42.45 | 2019 | |
| Cranial Technologies, INC | $41.72 | 2023-2024 | Doc Band |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $37.86 | 2021-2022 | |
| Amgen INC. | $28.85 | 2024 | Repatha, Otezla |
| Hologic Sales and Service, LLC | $21.58 | 2025 | Third Wave, Thinprep 2000 Processor, Aptima |
| Amarin Pharma, INC. | $21.49 | 2019 | |
| Lifescan, INC. | $18.79 | 2023 | |
| Abbvie INC. | $18.13 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $16.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Magner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.